Your session is about to expire
← Back to Search
Augmented Visual Feedback for Stroke Rehabilitation
N/A
Waitlist Available
Led By James Patton
Research Sponsored by Shirley Ryan AbilityLab
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4.5 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will study the feasibility and effects of error-augmented visual feedback during motion tracking with a Leap Motion device and the LookingGlass for people with different levels of stroke severity.
Who is the study for?
This trial is for adults who had a stroke at least 8 months ago, can move their shoulder and elbow against gravity to reach forward, but not for those with severe muscle stiffness, recent Botox in the arm, or other rehab treatments. It excludes pregnant women, children, prisoners, people with multiple strokes or severe sensory issues in the limb.
What is being tested?
The study tests if augmented visual feedback using Leap Motion and Looking Glass helps improve movement more than standard feedback. Participants are divided into healthy individuals; acute stroke survivors (recent stroke); and chronic survivors (older stroke), each receiving different interventions.
What are the potential side effects?
Since this is a non-invasive intervention focusing on motion tracking and visual feedback without drugs or surgery involved, there are no direct side effects expected from the technology itself.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4.5 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4.5 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Fugl Meyer Upper Extremity Score: Pre to Post/Discharge - Chronic and Acute Arms
Secondary study objectives
Action Research Arm Test Score: Pre to Follow-Up
Action Research Arm Test Score: Pre to Post
Amount of use
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
5Treatment groups
Experimental Treatment
Active Control
Group I: Chronic Veridical Visual FeedbackExperimental Treatment1 Intervention
Reaching while sitting at the Looking Glass system. The representation of arm movements will directly reflect the participants actual arm movements.
Group II: Chronic Augmented Visual FeedbackExperimental Treatment1 Intervention
Reaching while sitting at the Looking Glass system. The representation of a participant's arm movements will be augmented to encourage different movement patterns and improved movement.
Group III: Acute Veridical Visual FeedbackExperimental Treatment1 Intervention
Reaching while sitting at the Looking Glass system. The representation of arm movements will directly reflect the participants actual arm movements.
Group IV: Acute Augmented Visual FeedbackExperimental Treatment1 Intervention
Reaching while sitting at the Looking Glass system. The representation of a participant's arm movements will be augmented to encourage different movement patterns and improved movement.
Group V: HealthyActive Control1 Intervention
Healthy participants will participate in reaching activity using the Looking Glass and Leap motion tracking system
Find a Location
Who is running the clinical trial?
Shirley Ryan AbilityLabLead Sponsor
208 Previous Clinical Trials
17,950 Total Patients Enrolled
74 Trials studying Stroke
8,692 Patients Enrolled for Stroke
James PattonPrincipal Investigator - Shirley Ryan AbilityLab and University of Illinois at Chicago (UIC)
Shirley Ryan AbilityLab
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are not able to stay in the required testing positions.You have major loss of feeling in the affected limb.You have very severe muscle stiffness that makes it hard to move your elbow.You have difficulty speaking, thinking, or managing your emotions that would make it hard for you to take part in the study.You have many areas of damage in your body or have had multiple strokes.You had Botox injections in the affected arm within the last 4 months.You are currently doing therapy for your arms or hands, either as part of a research study or prescribed by a doctor.You have taken part in similar studies involving robotics interventions before.You had a stroke 8 months ago.I'm not familiar with the term "FMUE 15-50." Can you provide more context or information so I can assist you better?You are able to move your shoulder and elbow to reach 30 cm in different directions.You have difficulty seeing the target due to neglecting one side of your vision or having a visual field cut.Weakness in both sides of the body.
Research Study Groups:
This trial has the following groups:- Group 1: Chronic Augmented Visual Feedback
- Group 2: Acute Augmented Visual Feedback
- Group 3: Healthy
- Group 4: Acute Veridical Visual Feedback
- Group 5: Chronic Veridical Visual Feedback
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger